Top in ID: Antibiotic-resistant bacteria from pets, oral treatment for complicated UTI
Click Here to Manage Email Alerts
Cats and dogs may be spreading antibiotic-resistant bacteria to their owners, according to a recent study.
Researchers tested stool samples from humans and companion animals in 83 households. In two of these households, the researchers found evidence of cephalosporin-resistant Escherichia coli sharing among pets and owners. It was the top story in infectious disease last week.
Another top story highlighted results from a phase 3 trial that found oral tebipenem pivoxil hydrobromide is at least as good as IV ertapenem in the treatment of complicated UTI and acute pyelonephritis. According to researchers, 93.1% of patients who received tebipenem pivoxil hydrobromide experienced a clinical cure compared with 93.6% of patients who received ertapenem.
Read these and more top stories in infectious disease below:
Cats and dogs may pass antibiotic-resistant bacteria to their owners
Cats and dogs could be passing antibiotic-resistant bacteria and resistance genes to their owners, according to study findings that will be presented this month at the European Congress of Clinical Microbiology and Infectious Diseases. Read more.
Oral tebipenem pivoxil hydrobromide shows promise for complicated UTI
Oral tebipenem pivoxil hydrobromide is noninferior to IV ertapenem for the treatment of complicated UTI and acute pyelonephritis, according to the results of a phase 3 trial published in The New England Journal of Medicine. Read more.
These steps may identify patients eligible for shorter DAA therapy
Measuring hepatitis C virus at baseline and on days 7 and 14 of therapy — and eliminating blood draws on days 2 and 28 — can identify patients who may be eligible for a shorter duration of therapy, according to a study. Read more.
$1 billion fund seeking new antibiotics targets phages with first investments
A $1 billion public-private partnership seeking new antibiotics announced its first investments. Read more.
Duration of symptoms shorter with omicron, app-based data show
Vaccinated people who were subsequently infected with SARS-CoV-2 experienced a shorter duration of symptoms if they were infected with the omicron variant vs. the delta variant, mobile-app based data showed. Read more.